Aligos Therapeutics, Inc. (ALGS)
5.76
-0.45
(-7.25%)
USD |
NASDAQ |
Sep 08, 16:00
6.40
+0.64
(+11.11%)
After-Hours: 07:04
Aligos Therapeutics Market Cap : 35.92M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 35.92M |
| September 04, 2026 | 38.73M |
| September 03, 2026 | 38.79M |
| September 02, 2026 | 38.73M |
| September 01, 2026 | 37.98M |
| August 31, 2026 | 36.55M |
| August 28, 2026 | 43.10M |
| August 27, 2026 | 44.09M |
| August 26, 2026 | 46.84M |
| August 25, 2026 | 46.59M |
| August 24, 2026 | 43.22M |
| August 21, 2026 | 41.60M |
| August 20, 2026 | 40.16M |
| August 19, 2026 | 42.97M |
| August 18, 2026 | 42.16M |
| August 17, 2026 | 41.01M |
| August 14, 2026 | 42.97M |
| August 13, 2026 | 42.22M |
| August 12, 2026 | 43.66M |
| August 11, 2026 | 45.40M |
| August 10, 2026 | 47.71M |
| August 07, 2026 | 34.86M |
| August 06, 2026 | 34.36M |
| August 05, 2026 | 29.56M |
| August 04, 2026 | 29.62M |
| Date | Value |
|---|---|
| August 03, 2026 | 28.47M |
| July 31, 2026 | 26.18M |
| July 30, 2026 | 26.73M |
| July 29, 2026 | 26.30M |
| July 28, 2026 | 26.30M |
| July 27, 2026 | 25.25M |
| July 24, 2026 | 25.25M |
| July 23, 2026 | 29.02M |
| July 22, 2026 | 31.87M |
| July 21, 2026 | 33.66M |
| July 20, 2026 | 32.67M |
| July 17, 2026 | 35.52M |
| July 16, 2026 | 35.58M |
| July 15, 2026 | 35.71M |
| July 14, 2026 | 37.78M |
| July 13, 2026 | 39.36M |
| July 10, 2026 | 40.97M |
| July 09, 2026 | 41.89M |
| July 08, 2026 | 41.65M |
| July 07, 2026 | 37.69M |
| July 06, 2026 | 36.20M |
| July 02, 2026 | 34.59M |
| July 01, 2026 | 33.73M |
| June 30, 2026 | 35.71M |
| June 29, 2026 | 33.60M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 316.63M |
| Amgen, Inc. | 212.55B |
| Anika Therapeutics, Inc. | 281.58M |
| BioCryst Pharmaceuticals, Inc. | 2.314B |
| Imunon, Inc. | 7.185M |
Market Cap Related Metrics
| PS Ratio | 1.90 |
| Price to Book Value | 1.127 |
| Price | 5.76 |
| Earnings Yield | -127.0% |